Skip to main content
User menu
Subscribe
Donate
The HIV Treatment Journal of
Webinars
Current Issue
Drug Guides
Trending
COVID-19 and HIV
HIV Decriminalization
Hepatitis C
U=U
HIV & Aging
HIV Basics
HIV Cure Research
HIV Prevention
HIV Treatment
Stigma & Discrimination
POZ Advocate
Archive
About
Who We Are
Advertise
Contact
Subscribe
Reader/Customer Service
News
Donate
Donate
Bulk Subscriber Donation
Search
10 Years of the U=U campaign: Where it’s succeeded—and fallen short
Being Bridgette: Community and clinicians meet
Biktarvy is among the 15 drugs facing Medicare price negotiations
Back to top
Search
Advocates urge Paramount to keep PrEP awareness ad on TV Land
Finding community through bold self-expression
At AIDS 2026, activists disrupt session led by PEPFAR official
‘Innovation without access is injustice’: Global leaders urge recommitment to…
New Gilead campaign encourages young Black adults to get ‘Up to Date’ on HIV…
In an era of uncertainty, a renewed call to activism
Once-weekly pill matches daily oral HIV treatment in phase 3 studies
How Trump’s PEPFAR restrictions threaten the HIV global response
A demand for bodily autonomy—and data privacy—for people with HIV
What Black social workers must say and do about HIV
Pagination
Current page
1
Page
2
Page
3
Page
4
…
Next page
››
Last page
Last »
